Narjust Florez: Challenges faced by young patients with lung cancer
Narjust Florez shared a post by The Florez Lab on X, adding:
“Young patients with lung cancer face many unique challenges:
- Delayed diagnosis
- Limited treatment options
- Family and financial challenges .”
Quoting The Florez Lab’s post:
“Other unique challenges associated with young lung cancer:
- Delayed diagnosis
- Limited treatment options
- Financial strain
- Increased risk of depression
- Parenting challenges
- School/career disruption
- Peer isolation.”
Source: Narjust Florez/X and The Florez Lab/X
Narjust Florez is the Associate Director of the Cancer Care Equity Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer. She received the 2020 Rising Star award by the LEAD National Conference for women in hematology and oncology. In addition, Dr. Florez founded the Florez Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine, and medical education.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023